GLEN Industries
GLENINDUSTRIESLTD NSE
GLEN Industries
HealthcareNSE: GLENINDUSTRIESLTD BSE: GLEN Pharmaceuticals
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹304 Cr
Volatility
Moderate
P/E Ratio
18.5
EBITDA
₹39.10 Cr
Return on Equity
11.82%
Debt to Equity
0.87
Book Value
₹54.64
52W High
₹134
52W Low
₹58
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
Growth Rate
Revenue Growth
19.79% lower than
3Y
Net Income Growth
-9.34% lower than
3Y
Cash Flow Change
1.39% higher than
3Y
ROE
-62.08% lower than
3Y
ROCE
-37.3% lower than
3Y
EBITDA Margin (Avg.)
-20.2% lower than
3Y
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 84 | 87 | 96 | 108 |
| Expenses | 66 | 64 | 76 | 90 |
| Operating Profit | 18 | 23 | 19 | 18 |
| OPM % | 21% | 26% | 20% | 17% |
| Other Income | 1 | 0 | 1 | 1 |
| Interest | 4 | 6 | 5 | 5 |
| Depreciation | 4 | 4 | 4 | 4 |
| PBT | 11 | 13 | 11 | 11 |
| Tax % | 25% | 26% | 25% | 23% |
| Net Profit | 8 | 10 | 8 | 8 |
| EPS in Rs | 4.84 | 5.53 | 3.45 | 3.41 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 92 | 115 | 140 | 166 | 199 |
| Expenses | 81 | 99 | 115 | 126 | 162 |
| Operating Profit | 11 | 16 | 25 | 40 | 37 |
| OPM % | 12% | 14% | 18% | 24% | 19% |
| Other Income | 3 | -2 | 0 | 1 | 2 |
| Interest | 4 | 6 | 7 | 9 | 9 |
| Depreciation | 5 | 6 | 6 | 7 | 8 |
| PBT | 5 | 3 | 11 | 24 | 22 |
| Tax % | 27% | 44% | 25% | 25% | 24% |
| Net Profit | 4 | 1 | 9 | 18 | 16 |
| EPS in Rs | 35.62 | 14.42 | 82.46 | 10.37 | 6.86 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 18 | 32 |
| Reserves | 17 | 31 | 40 | 41 | 107 |
| Borrowings | 77 | 86 | 94 | 133 | 121 |
| Other Liabilities | 22 | 19 | 26 | 23 | 30 |
| Total Liabilities | 116 | 137 | 161 | 214 | 291 |
| Fixed Assets | 55 | 73 | 81 | 108 | 108 |
| CWIP | 1 | 0 | 0 | 1 | 12 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 60 | 64 | 80 | 106 | 170 |
| Total Assets | 116 | 137 | 161 | 214 | 291 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | -14 | 11 | 14 | 6 | 6 |
| Investing | -22 | -15 | -13 | -35 | -18 |
| Financing | 34 | 4 | -2 | 30 | 11 |
| Net Cash Flow | -2 | 0 | -1 | 1 | -1 |
| Free Cash Flow | -29 | -2 | 0 | -29 | -14 |
| CFO/OP | -124 | 75 | 57 | 20 | 32 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 61 | 52 | 69 | 68 | 68 |
| Inventory Days | 192 | 192 | 184 | 252 | 240 |
| Days Payable | 34 | 42 | 51 | 25 | 41 |
| Cash Conversion Cycle | 219 | 202 | 203 | 294 | 267 |
| Working Capital Days | 6 | -6 | 4 | 4 | 25 |
| ROCE % | — | 10% | 15% | 20% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view GLEN Industries insights
51 extracted metrics + investor summaries across FY22–FY26.
Documents
2
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Consolidated And Standalone Unaudited Financial Results For The Half Year And Financial Year Ended 31.03.2026
27 May - Board approved audited standalone and consolidated FY26 results on 27 May 2026; unmodified audit opinion. 27 May - Board approved audited standalone and consolidated FY26 results on 27 May 2026; unmodified audit opinion.
3
Announcement Under Regulation 30(LODR)- Business Update
9 Apr - FY26 revenue rose 19.02% to ₹203.13 Cr; food container capacity expanded to 21,095 MT. 9 Apr - FY26 revenue rose 19.02% to ₹203.13 Cr; food container capacity expanded to 21,095 MT.
4
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations , 2018 for the quarter ended 31.03.2026 9 Apr - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations , 2018 for the quarter ended 31.03.2026
Frequently Asked Questions about GLEN Industries
What does GLEN Industries Ltd do?
Incorporated in 2007, Glen Industries Limited (GIL) is engaged in the manufacturing of eco-friendly food packaging and service products.[1]
Where is GLEN Industries Ltd (544444) listed?
GLEN Industries Ltd trades as GLENINDUSTRIESLTD on the NSE and under code GLEN on the BSE.
Which sector does GLEN Industries Ltd belong to?
GLEN Industries Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of GLEN Industries Ltd?
GLEN Industries Ltd has a market capitalisation of ₹304.42 Cr, which places it in the Small Cap band.
What is the PE ratio of GLEN Industries Ltd?
GLEN Industries Ltd trades at a PE ratio of 18.50, against a book value of ₹54.64 per share.
What is the 52-week high and low of GLEN Industries Ltd?
Over the last 52 weeks GLEN Industries Ltd has traded between ₹58 and ₹134.
What is the Return on Equity (ROE) of GLEN Industries Ltd?
GLEN Industries Ltd reported a return on equity of 11.82%. Its debt-to-equity ratio is 0.87.
Company Information
Incorporated in 2007, Glen Industries Limited (GIL) is engaged in the manufacturing of eco-friendly food packaging and service products.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544444.md for GLEN Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.